Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 7.43 MYR
Change Today +0.15 / 2.06%
Volume 268.8K
PHRM On Other Exchanges
Symbol
Exchange
Kuala Lumpur
As of 4:55 AM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

pharmaniaga berhad (PHRM) Snapshot

Open
7.28
Previous Close
7.28
Day High
7.43
Day Low
7.22
52 Week High
04/24/15 - 7.43
52 Week Low
12/15/14 - 4.10
Market Cap
1.9B
Average Volume 10 Days
376.3K
EPS TTM
0.36
Shares Outstanding
258.9M
EX-Date
03/9/15
P/E TM
20.5x
Dividend
0.28
Dividend Yield
3.77%
Current Stock Chart for PHARMANIAGA BERHAD (PHRM)

Related News

No related news articles were found.

pharmaniaga berhad (PHRM) Related Businessweek News

No Related Businessweek News Found

pharmaniaga berhad (PHRM) Details

Pharmaniaga Berhad, an investment holding company, operates as an integrated healthcare company in Malaysia and Indonesia. It operates through Logistics and Distribution, and Manufacturing segments. The company is involved in the manufacture and sale of generic pharmaceutical products; trading and wholesale of consumer products; supply, trading, and installation of medical and hospital equipment; and distribution and trading of pharmaceutical products, medical products, food supplements, and diagnostic products. It also engages in the research and development of pharmaceutical products. The company is based in Shah Alam, Malaysia. Pharmaniaga Berhad is a subsidiary of Boustead Holdings Berhad.

2,972 Employees
Last Reported Date: 03/9/15

pharmaniaga berhad (PHRM) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

pharmaniaga berhad (PHRM) Key Developments

Pharmaniaga Mulls Acquisitions

Pharmaniaga Bhd (KLSE:PHARMA) is seeking acquisitions. Chairman Tan Sri Lodin Wok Kamaruddin said, "We're open to new opportunities for growth, be it via acquisitions or organically, in order to enhance our core business."

Pharmaniaga Bhd, Annual General Meeting, Mar 31, 2015

Pharmaniaga Bhd, Annual General Meeting, Mar 31, 2015., at 10:00 Singapore Standard Time. Location: The Royale Chulan Damansara Hotel.

Pharmaniaga Plans to Expand its Portfolio and Increase Research and Development to Tap Rising Demand for Healthcare in Malaysia

Pharmaniaga plans to expand its portfolio and increase research and development to tap rising demand for healthcare in Malaysia, as well as continue its cost-control measures. The company also plans to expand its manufacturing activities, in part through collaborations with companies in Europe.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PHRM:MK 7.43 MYR +0.15

PHRM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for PHRM.
View Industry Companies
 

Industry Analysis

PHRM

Industry Average

Valuation PHRM Industry Range
Price/Earnings 20.0x
Price/Sales 0.9x
Price/Book 3.6x
Price/Cash Flow 17.7x
TEV/Sales 0.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PHARMANIAGA BERHAD, please visit www.pharmaniaga.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.